INNOClinical Trials•prnewswire•August 22, 2025 at 08:00 PM

Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada

Sentiment:Neutral (55)

Summary

PAINWeek is the premier US conference in pain management Innocan's Poster "Is Long-Acting Synthetic Cannabidiol a Solution to Chronic Pain?" to be highlighted HERZLIYA, Israel and CALGARY, AB, Aug. 22, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF)...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 22, 2025 by prnewswire